ArticleJournal of translational medicine2025

Tumor immune microenvironment score predicts efficacy of immune checkpoint inhibitors-based regimens in advanced non-small cell lung cancer.

Jiacheng Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.